About Klinik St. Marienstift
"Auf Grund der derzeitigen Corona-Pandemie besteht noch ein Besuchsverbot. Ansonsten sind Besucher täglich herzlich willkommen und wichtig für die Genesung Ihrer Angehörigen! Unsere Besuchszeiten sind: Station 1 - 14.30 - 18.30 Uhr Station 2 - 14.00 - 18.00 Uhr Station 3 A - 14.30 - 18.00 Uhr Station 3 B - 14.30 - 18.00 Uhr Station 3 C - 14.30 - 18.00 Uhr Intensivstation - nach Absprache"
Clinical Trials at Klinik St. Marienstift
During the past decade, Klinik St. Marienstift conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik St. Marienstift"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Scottish Gynaecological Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Klinik St. Marienstift
According to Clinical.Site data, the most researched conditions in "Klinik St. Marienstift" are
"Ovarian Cancer" (1 trials) and "Recurrent Platinum-sensitive Ovarian Cancer" (1 trials). Many other conditions were trialed in "Klinik St. Marienstift" in a lesser frequency.
Clinical Trials Intervention Types at Klinik St. Marienstift
Most popular intervention types in "Klinik St. Marienstift" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abagovomab" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "PLD" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinik St. Marienstift
The vast majority of trials in "Klinik St. Marienstift" are
2 trials for "Female" genders.
Clinical Trials Status at Klinik St. Marienstift
Currently, there are NaN active trials in "Klinik St. Marienstift".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinik St. Marienstift,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinik St. Marienstift, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".